NBY

Q: What is the price of NovaBay Pharmaceuticals Inc (NBY) today?

The current price of NovaBay Pharmaceuticals Inc (NBY) is $ 1.21, representing a 520.04% gain over the past year. The stock began the year trading around $ 5.64 and is currently priced at $ 1.21. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does NovaBay Pharmaceuticals Inc (NBY) pay dividends?

NovaBay Pharmaceuticals Inc (NBY) did not pay dividends over the past year.

NovaBay Pharmaceuticals Inc

Price

$ 1.21

return (12m)

520.04%

p/e

0.06

p/bv

0.24

DIVIDEND YIELD

314.96%

NBY price

NovaBay Pharmaceuticals Inc

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NBY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-15.38%

3 months

-12.95%

1 year

520.04%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NBY

review the fundamentals of NovaBay Pharmaceuticals Inc shares

P/E

0.06

Sector: 7.47 Industry: 7.47

P/S (PSR)

Sector: 2.32 Industry: 2.32

P/BV

0.24

Sector: 2.26 Industry: 2.26

DIVIDEND YIELD (DY)

314.96%

Sector: 0.66% Industry: 0.66%

ROA

290.70%

Sector: -0.36% Industry: -0.36%

ROE

376.38%

Sector: 3.50% Industry: 3.50%

ROIC

Sector: -160.51% Industry: -160.51%

NET MARGIN

0.00%

Sector: 2.97% Industry: 2.97%

GROSS MARGIN

0.00%

Sector: 32.00% Industry: 32.00%

OPERATING MARGIN

0.00%

Sector: 4.81% Industry: 4.81%

EV/EBITDA

-7.76

Sector: 2.85 Industry: 2.85

EV/EBIT

-7.54

Sector: 1.19 Industry: 1.19

PRICE-TO-ASSETS

0.18

Sector: 1.07 Industry: 1.07

BVPS

5.34

Sector: 10.03 Industry: 10.03

EPS

20.08

Sector: 0.70 Industry: 0.70

EQUITY-TO-ASSETS RATIO

0.77

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

0.23

Sector: 0.53 Industry: 0.53

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF NovaBay Pharmaceuticals Inc ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 1.21

Fair Value

$ 49.12

Upside Return potential.

3,959.37%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NBY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	22.71	6.58	28.97%	0.33%	$ 1.60 T	32.84%
INTR	292.53	37.99	12.99%	1.83%	$ 2.75 B	9.10%
PBR	5.99	1.42	23.78%	6.32%	$ 121.53 B	21.75%
VALE	24.33	1.85	7.59%	6.23%	$ 69.37 B	7.21%
PLTR	164.26	43.80	26.67%	0.00%	$ 374.76 B	43.67%
SHEL	12.57	1.35	10.74%	3.47%	$ 235.67 B	7.01%
BDORY	10.06	0.62	6.21%	2.79%	$ 23.52 B	8.65%
MAIN	10.93	1.51	13.78%	7.77%	$ 4.66 B	81.08%
NSRGY	11.15	6.29	56.41%	3.95%	$ 261.01 B	10.91%
ENB	23.46	2.39	10.18%	5.10%	$ 117.90 B	10.01%
PBR-A	5.35	1.27	23.78%	6.39%	$ 108.65 B	21.75%
ITUB	1,528.91	289.86	18.96%	1.98%	$ 87.36 B	12.16%
BBSEY	7.85	5.52	70.42%	11.67%	$ 13.35 B	100.00%
UNH	28.67	3.28	11.44%	2.32%	$ 345.32 B	2.68%
SAN	10.07	1.45	14.44%	1.62%	$ 189.11 B	27.40%
TTE	12.55	1.51	12.05%	6.43%	$ 189.31 B	8.20%
RACE	32.40	12.85	39.66%	1.25%	$ 60.22 B	22.18%
IONQ	78.54	5.15	6.56%	0.00%	$ 25.70 B	100.00%
TD	12.17	2.09	17.19%	2.71%	$ 190.81 B	34.54%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NBY Historical Dividends

current DY: 314.96%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/29/2025	09/29/2025	4,00000000
Dividends	09/29/2025	09/29/2025	4,00000000
Dividends	09/29/2025	09/29/2025	4,00000000
Dividends	09/29/2025	09/29/2025	4,00000000
Dividends	09/29/2025	09/29/2025	4,00000000
Dividends	09/29/2025	09/29/2025	4,00000000

ABOUT NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc

Average Investor10 user rating

4.0 (6 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

NovaBay Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $33.04 Millions, with shareholders equity totaling $138.83 Millions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, NovaBay Pharmaceuticals Inc reported $- in revenue, generating net income of $522.51 Millions.

Key financial metrics include a P/E ratio of 0.06, a price-to-book (P/B) ratio of 0.24, and a trailing twelve-month dividend yield of 314.96%.

The company trades under the ticker NBY.

Market cap

$ 33.04 Millions

Net worth

$ 138.83 Millions

$ 138,825,000.00

Assets

$ 179.74 Millions

$ 179,743,000.00

Total Shares Outstanding

26.02 Millions

26,015,000

Average Daily Trading Volume

$ 554.45 Thousand

$ 554,450.00

Sector

Others

Industry

Others

NBY

NBY revenue and profits

Financial Results NBY

DRAG THE FRAME TO SEE MORE DATA

NBY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

UNH - UnitedHealth Group Incorporated

$ 396.47 37,76% (12M)

P/E

28.67

2.32%

ROE

11.44%

P/BV

3.28

STLA - Stellantis NV

$ 7.39 --23,66% (12M)

P/E

-1.14

0.00%

ROE

-32.04%

P/BV

0.36

SSNLF - Samsung Electronics Co Ltd

$ - -0,00% (12M)

P/E

16.24

0.56%

ROE

17.46%

P/BV

2.84

CCOEY - Capcom Co Ltd ADR

$ 8.77 --39,49% (12M)

P/E

0.14

1.50%

ROE

20.55%

P/BV

0.03

COR - Cencora Inc.

$ 270.32 --5,56% (12M)

P/E

20.56

1.08%

ROE

71.09%

P/BV

14.62

SHEL - Shell PLC ADR

$ 86.73 34,81% (12M)

P/E

12.57

3.47%

ROE

10.74%

P/BV

1.35

NSRGY - Nestle SA ADR

$ 96.81 --4,88% (12M)

P/E

11.15

3.95%

ROE

56.41%

P/BV

6.29

META - Meta Platforms Inc.

$ 627.57 --7,98% (12M)

P/E

22.71

0.33%

ROE

28.97%

P/BV

6.58